Ryan Maynard - 29 Jun 2021 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Ryan Maynard
Issuer symbol
IOVA
Transactions as of
29 Jun 2021
Net transactions value
$0
Form type
4
Filing time
01 Jul 2021, 16:18:49 UTC
Next filing
02 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 29 Jun 2021 Common Stock 35,000 $26.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant, such that the options will be fully vested and exercisable on June 29, 2022.